Research progress of anti-Müllerian hormone in the diagnosis of polycystic ovary syndrome
10.3760/cma.j.cn101441-20200526-00310
- VernacularTitle:抗苗勒管激素用于多囊卵巢综合征诊断的研究进展
- Author:
Xieqin LIU
1
;
Jiuzhi ZENG
;
Weixin LIU
;
Yaqin WEI
Author Information
1. 成都医学院 610500
- Publication Type:Journal Article
- Keywords:
Polycystic ovary syndrome;
Anti-Müllerian hormone;
Hyperandrogenism
- From:
Chinese Journal of Reproduction and Contraception
2020;40(12):1026-1030
- CountryChina
- Language:Chinese
-
Abstract:
The level of anti-Müllerian hormone (AMH) in the serum of patients with polycystic ovary syndrome (PCOS) was higher than that of normal women. In recent years, more and more studies have suggested that the interaction between AMH and androgen causes follicular developmental disorder in PCOS patients, and AMH can be used as a biochemical indicator for the diagnosis of PCOS, especially in PCOS patients with hyperandrogenism. This paper reviews the prospects and challenges of AMH in the diagnosis of PCOS.
